Tonix Pharmaceuticals Holding Corp Stock Nasdaq
Stocks
US8902602015
Pharmaceuticals
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 218M 188M 177M 161M 303M 20.84B 307M 2.07B 811M 10.44B 818M 801M 34.69B | P/E 2026 * |
-1.31x | P/E 2027 * | -2.06x |
|---|---|---|---|---|---|
| Enterprise Value | 218M 188M 177M 161M 303M 20.84B 307M 2.07B 811M 10.44B 818M 801M 34.69B | EV / Sales 2026 * |
3.89x | EV / Sales 2027 * | 1.88x |
| Free-Float |
99.87% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tonix Pharmaceuticals Holding Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CEO | Chief Executive Officer | 68 | 2007-11-15 |
Bradley Saenger
DFI | Director of Finance/CFO | 52 | 2016-01-31 |
Siobhan Fogarty
CTO | Chief Tech/Sci/R&D Officer | 57 | 2025-02-03 |
| Director | Title | Age | Since |
|---|---|---|---|
Seth Lederman
CHM | Chairman | 68 | 2011-09-30 |
Margaret Bell
BRD | Director/Board Member | 66 | 2017-09-11 |
Adeoye Olukotun
BRD | Director/Board Member | 81 | 2018-09-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.25% | -0.47% | +68.30% | +115.90% | 1,052B | |
| -0.66% | +0.43% | +47.39% | +50.54% | 627B | |
| -0.54% | +1.39% | +20.69% | +63.99% | 441B | |
| -1.99% | -3.32% | +38.71% | +35.41% | 349B | |
| -1.05% | -2.81% | +23.07% | +35.70% | 287B | |
| -2.12% | -3.67% | -1.14% | +5.37% | 241B | |
| -0.63% | +1.04% | +40.05% | +56.09% | 224B | |
| -1.19% | -3.41% | -9.57% | -52.71% | 202B | |
| +0.16% | +3.87% | +16.89% | +73.73% | 172B | |
| Average | -1.14% | +0.43% | +27.15% | +42.67% | 399.46B | |
| Weighted average by Cap. | -1.36% | +0.32% | +39.09% | +61.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 56.04M 48.4M 45.48M 41.36M 77.76M 5.36B 79.05M 533M 208M 2.68B 210M 206M 8.92B | 116M 100M 94.26M 85.72M 161M 11.11B 164M 1.1B 432M 5.56B 436M 427M 18.48B |
| Net income | -168M -145M -136M -124M -233M -16.05B -237M -1.6B -624M -8.04B -630M -617M -26.71B | -153M -132M -124M -113M -212M -14.61B -216M -1.45B -568M -7.32B -574M -561M -24.32B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
